{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:50:51Z","timestamp":1789800651660,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1245\/s10434-021-11140-5","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T06:07:58Z","timestamp":1641535678000},"page":"2263-2272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Can We Successfully De-Escalate Axillary Surgery in Women Aged \u2265 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy?"],"prefix":"10.1245","volume":"29","author":[{"given":"Regina","family":"Matar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea V.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varadan","family":"Sevilimedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiana","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Heerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audree","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"11140_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00000658-198302000-00001","volume":"197","author":"KS McCarty Jr","year":"1983","unstructured":"McCarty KS Jr, Silva JS, Cox EB, et al. Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. Ann Surg. 1983;197:123\u20137.","journal-title":"Ann Surg."},{"key":"11140_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/jnci\/92.7.550","volume":"92","author":"SG Diab","year":"2000","unstructured":"Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000;92:550\u20136.","journal-title":"J Natl Cancer Inst."},{"key":"11140_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djv159","volume":"107","author":"PS Rosenberg","year":"2015","unstructured":"Rosenberg PS, Barker KA, Anderson WF. Estrogen receptor status and the future burden of invasive and in situ breast cancers in the United States. J Natl Cancer Inst. 2015;107:1\u20137.","journal-title":"J Natl Cancer Inst."},{"key":"11140_CR4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/jnci\/djs264","volume":"104","author":"CA Clarke","year":"2012","unstructured":"Clarke CA, Keegan THM, Yang J, et al. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst. 2012;104:1094\u2013101.","journal-title":"J Natl Cancer Inst."},{"key":"11140_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1524-4741.1997.tb00180.x","volume":"3","author":"B Cady","year":"1997","unstructured":"Cady B. Is axillary lymph node dissection necessary in routine management of breast cancer? No. Breast. 1997;3:246\u201360.","journal-title":"Breast"},{"key":"11140_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00268-002-6506-2","volume":"26","author":"ME Newlin","year":"2002","unstructured":"Newlin ME, Reiling R, Nichols K. Necessity of axillary dissection in elderly women with early breast cancer. World J Surg. 2002;26:1239\u201342.","journal-title":"World J Surg."},{"key":"11140_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.amjsurg.2010.02.005","volume":"201","author":"AK Karam","year":"2011","unstructured":"Karam AK, Hsu M, Patil S, et al. Determinants of outcome in elderly patients with positive sentinel lymph nodes. Am J Surg. 2011;201:734\u201340.","journal-title":"Am J Surg."},{"key":"11140_CR8","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382\u20137.","journal-title":"J Clin Oncol."},{"key":"11140_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMoa040587","volume":"351","author":"KS Hughes","year":"2004","unstructured":"Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971\u20137.","journal-title":"N Engl J Med."},{"key":"11140_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1245\/s10434-010-1217-7","volume":"18","author":"G Martelli","year":"2011","unstructured":"Martelli G, Miceli R, Daidone MG, et al. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol. 2011;18:125\u201333.","journal-title":"Ann Surg Oncol."},{"key":"11140_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamasurg.2015.0647","volume":"150","author":"A Chung","year":"2015","unstructured":"Chung A, Gangi A, Amersi F, et al. Not performing a sentinel node biopsy for older patients with early-stage invasive breast cancer. JAMA Surg. 2015;150:683\u20134.","journal-title":"JAMA Surg."},{"key":"11140_CR12","unstructured":"The Society of Surgical Oncology. Five things physicians and patients should question as part of choosing wisely campaign. Updated June 20, 2019. https:\/\/www.choosingwisely.org\/clinician-lists\/sso-sentinel-node-biopsy-in-node-negative-women-70-and-over\/. Accessed April 15, 2021."},{"key":"11140_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1200\/JCO.2005.01.5784","volume":"24","author":"CM Rudenstam","year":"2006","unstructured":"Rudenstam CM, Zahrieh D, Forbes JF, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group trial 10\u201393. J Clin Oncol. 2006;24:337\u201344.","journal-title":"J Clin Oncol."},{"issue":"1","key":"11140_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2482-15-1","volume":"15","author":"A Neri","year":"2015","unstructured":"Neri A, Marrelli D, Megha T, et al. Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases. BMC Surg. 2015;15(1):1.","journal-title":"BMC Surg."},{"key":"11140_CR15","doi-asserted-by":"crossref","unstructured":"Amin MB, Edge S, Greene F, et al., eds. AJCC Cancer Staging Manual. 8th Edition. Springer; 2017.","DOI":"10.1007\/978-3-319-40618-3"},{"key":"11140_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1245\/ASO.2005.02.013","volume":"12","author":"J Caywood","year":"2005","unstructured":"Caywood J, Gray RJ, Hentz J, et al. Older age independently predicts a lower risk of sentinel lymph node metastasis in breast cancer. Ann Surg Onc. 2005;12:1061\u20135.","journal-title":"Ann Surg Onc."},{"key":"11140_CR17","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/cncr.32668","volume":"126","author":"SM Downs-Canner","year":"2020","unstructured":"Downs-Canner SM, Gaber CE, Louie RJ, et al. Nodal positivity decreases with age in women with early-stage, hormone receptor\u2013positive breast cancer. Cancer. 2020;126:1193\u2013201.","journal-title":"Cancer."},{"key":"11140_CR18","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1245\/s10434-017-5932-1","volume":"24","author":"JL Welsh","year":"2017","unstructured":"Welsh JL, Hoskin TL, Day CN, et al. Predicting nodal positivity in women 70 years of age and older with hormone receptor-positive breast cancer to aid incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into clinical practice. Ann Surg Oncol. 2017;24:2881\u20138.","journal-title":"Ann Surg Oncol."},{"key":"11140_CR19","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1245\/s10434-016-5740-z","volume":"24","author":"JC Boughey","year":"2017","unstructured":"Boughey JC, Haffty BG, Haberman EB, et al. Has the time come to stop surgical staging of the axilla for all women age 70 years or older with hormone receptor-positive breast cancer? Ann Surg Oncol. 2017;24:614\u20137.","journal-title":"Ann Surg Oncol."},{"key":"11140_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1245\/s10434-017-6156-0","volume":"24","author":"F Fitzal","year":"2017","unstructured":"Fitzal F, Helfgott R, Moinfar F, et al. Sized influences nodal status in women aged #70 with endocrine responsive breast cancer. Ann Surg Oncol. 2017;24:555\u20136.","journal-title":"Ann Surg Oncol."},{"key":"11140_CR21","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1245\/s10434-017-5936-x","volume":"24","author":"AB Chagpar","year":"2017","unstructured":"Chagpar AB, Hatzis C, Pusztai L, et al. Association of LN evaluation with survival in women aged 70 years or older with clinically node-negative hormone receptor positive breast cancer. Ann Surg Oncol. 2017;24:3073\u201381.","journal-title":"Ann Surg Oncol."},{"key":"11140_CR22","first-page":"2927","volume":"39","author":"B Fisher","year":"1977","unstructured":"Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer a first report of results from a prospective randomized clinical trial. Cancer. 1977;39:2927\u20132839.","journal-title":"Cancer."},{"key":"11140_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1056\/NEJM198503143121102","volume":"312","author":"B Fisher","year":"1985","unstructured":"Fisher B, Redmond C, Fisher E, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674\u201381.","journal-title":"N Engl J Med."},{"key":"11140_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Ernard","year":"2002","unstructured":"Ernard B, Isher F, Ong -H, Yeon J, et al. Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567\u201375.","journal-title":"N Engl J Med."},{"key":"11140_CR25","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"O Abe","year":"2005","unstructured":"Abe O, Abe R, Enomoto K, et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687\u2013717.","journal-title":"Lancet."},{"key":"11140_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","volume":"16","author":"IH Kunkler","year":"2015","unstructured":"Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM. PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16:266\u201373.","journal-title":"Lancet Oncol."},{"key":"11140_CR27","unstructured":"Kalinsky K, Barlow WE, Meric-Bernstam F, et al. First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +\/-chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25: SWOG S1007 (RxPonder). Presented at: 2020 San Antonio Breast Cancer Symposium."},{"key":"11140_CR28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(00)02263-7","volume":"355","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2000","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355:1757\u201370.","journal-title":"Lancet."},{"key":"11140_CR29","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","volume":"32","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365\u201383.","journal-title":"J Clin Oncol."},{"key":"11140_CR30","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1245\/s10434-007-9414-8","volume":"14","author":"KH Moore","year":"2007","unstructured":"Moore KH, Sweeney KJ, Wilson ME, et al. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Ann Surg Oncol. 2007;14:2911\u20137.","journal-title":"Ann Surg Oncol."},{"key":"11140_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1245\/s10434-006-9211-9","volume":"14","author":"JCC Tan","year":"2007","unstructured":"Tan JCC, McCready DR, Easson AM, et al. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Ann Surg Oncol. 2007;14:638\u201345.","journal-title":"Ann Surg Oncol."},{"key":"11140_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1245\/s10434-013-3239-4","volume":"21","author":"L Chin-Lenn","year":"2014","unstructured":"Chin-Lenn L, Mack LA, Temple W, et al. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy. Ann Surg Oncol. 2014;21:66\u201373.","journal-title":"Ann Surg Oncol."},{"key":"11140_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/tbj.13737","volume":"26","author":"A Price","year":"2020","unstructured":"Price A, Schnabel F, Chun J, et al. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS). Breast. 2020;26:931\u20136.","journal-title":"Breast."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-11140-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-11140-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-11140-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T01:04:05Z","timestamp":1647651845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-11140-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["11140"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-11140-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"16 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Monica Morrow has received speaking honoraria from Roche and Exact Sciences. All other authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study was presented in poster format at the Society of Surgical Oncology 2021 International Conference on Surgical Cancer Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Presentation"}}]}}